---
phase: 11-supplement-and-drug-database
plan: 02
subsystem: data
tags: [interactions, supplements, drugs, longevity, pharmacist, react-native, typescript]

# Dependency graph
requires:
  - phase: 11-01
    provides: INTERACTIONS array baseline (30 pairs) and InteractionCheckerScreen structure
provides:
  - Expanded INTERACTIONS array with 54 pharmacist-reviewed pairs (23 new, covering HIGH/MODERATE/LOW/BENEFICIAL)
  - Expanded SAFE_COMBOS with 11 synergistic longevity pairs (was 4)
  - Pharmacist checkpoint completion — all pairs reviewed and approved
affects:
  - InteractionCheckerScreen (data source for drug/supplement conflict checking)
  - Phase 11 plan 03/04 (auto-populate and chip redesign will have rich data to render)

# Tech tracking
tech-stack:
  added: []
  patterns:
    - "Interaction entry shape: id, drug, supplement, severity as const, title, body, recommendation — all fields mandatory"
    - "SAFE_COMBOS shape: { pair: string; body: string } — body must include mechanism and dosing"
    - "Phase 11 additions block with [PHARMACIST REVIEW REQUIRED] comment + Stockley/Medscape source citation"

key-files:
  created: []
  modified:
    - src/data/biomarkers.ts
    - src/screens/InteractionCheckerScreen.tsx

key-decisions:
  - "Pharmacist checkpoint gates all new interaction data — no pair ships without explicit approval"
  - "severity field uses TypeScript 'as const' assertion on all entries to prevent typos at type-check time"
  - "SAFE_COMBOS expanded with full clinical body text (mechanism + dosing) rather than one-liner descriptions"
  - "Beneficial pairs added to INTERACTIONS (not just SAFE_COMBOS) so they surface in the interaction checker tab"

patterns-established:
  - "Interaction data pattern: drug field uses sentence-case ('Warfarin', 'Statin') — lookup uses .toLowerCase() so case is for readability"
  - "New pairs added in a clearly-marked comment block with source citation for traceability"

requirements-completed:
  - SUPP-03
  - SUPP-04

# Metrics
duration: multi-session (Task 1 prior session, Task 3 current session)
completed: 2026-06-04
---

# Phase 11 Plan 02: Interaction Pairs and Safe Combos Summary

**54-pair pharmacist-reviewed INTERACTIONS dataset and 11-entry SAFE_COMBOS array enabling the full longevity supplement + drug conflict checker**

## Performance

- **Duration:** Multi-session (Task 1 committed prior session; Task 3 current session)
- **Completed:** 2026-06-04
- **Tasks:** 3 (Task 1: data expansion, Task 2: pharmacist checkpoint, Task 3: SAFE_COMBOS)
- **Files modified:** 2

## Accomplishments

- Added 23 new interaction pairs to `src/data/biomarkers.ts` bringing total to 54 pairs (up from 31)
- Covered all major longevity stacks: CBD+Warfarin (HIGH, CYP2C9), Rapamycin+St. John's Wort (HIGH, CYP3A4), NMN+Apigenin (BENEFICIAL, NAD+ synergy), GlyNAC (BENEFICIAL, 2023 RCT), Spermidine+Fisetin (BENEFICIAL, autophagy+senolysis)
- Pharmacist checkpoint completed and approved — all severity classifications, mechanisms, and recommendations verified
- Expanded SAFE_COMBOS from 4 brief entries to 11 richly-described synergistic pairs with mechanism and dosing info
- tsc --noEmit: zero TypeScript errors across both files

## Task Commits

Each task was committed atomically:

1. **Task 1: Add 23 new interaction pairs to INTERACTIONS in biomarkers.ts** - `377c148` (feat)
2. **Task 2: Pharmacist review checkpoint** - approved (no code commit — human review gate)
3. **Task 3: Expand SAFE_COMBOS to 11 entries** - `25d9d33` (feat)

## Files Created/Modified

- `src/data/biomarkers.ts` - INTERACTIONS array expanded from 31 to 54 pairs; 23 new entries covering HIGH/MODERATE/LOW/BENEFICIAL severity levels across warfarin, statin, insulin, rapamycin, and antihypertensive drug classes
- `src/screens/InteractionCheckerScreen.tsx` - SAFE_COMBOS expanded from 4 to 11 entries; existing entries updated with full clinical body text; 7 new pairs added (NMN+Apigenin, Urolithin A+NMN, Spermidine+Fisetin, GlyNAC, Omega-3+Curcumin, NMN+Resveratrol+TMG, Berberine+ALA)

## Decisions Made

- Pharmacist checkpoint (Task 2) gates all new interaction data — no pair ships without explicit licensed-pharmacist approval. This is the primary safety control for T-11-03 and T-11-04 threat mitigations.
- Severity field uses TypeScript `as const` assertions on all new entries to catch typos at compile time.
- SAFE_COMBOS body text expanded to include mechanism description and dosing guidance (not just one-liners) — more useful for end users scanning the "Safe combos" tab.
- Beneficial interactions added to both INTERACTIONS array (so they appear in the checker tab) and SAFE_COMBOS (so they appear in the safe combos tab), giving maximum visibility.

## Deviations from Plan

None - plan executed exactly as written. Pharmacist checkpoint approved all 23 pairs without corrections.

## Issues Encountered

None.

## User Setup Required

None - no external service configuration required.

## Next Phase Readiness

- INTERACTIONS array has 54 pairs — sufficient data for Phase 11 plan 03/04 auto-populate and chip redesign to produce non-empty results for typical longevity stacks
- SAFE_COMBOS has 11 entries — Safe combos tab now substantively useful
- Both SUPP-03 (interaction data coverage) and SUPP-04 (recommendation field on every pair) are satisfied
- No blockers for downstream plans

---
*Phase: 11-supplement-and-drug-database*
*Completed: 2026-06-04*
